|
21 January 2012: Health professions call for international law against falsified and counterfeit medical products
Presenting an intervention on Substandard/Spurious/Falsely-Labelled/Falsified/Counterfeit Medical Products (SSFFC) medicines at the WHO Executive Board meeting, the International Pharmaceutical Federation, representing WHPA, called for an expert group to report back to the next EB and WHA in 2013 on the feasibility of establishing a public health treaty on combating SSFFC medicines, based on the model of theFramework Convention on Tobacco Control. (See full text here)
19 January 2012: Health professions present NCD intervention at WHO Executive Board meeting
WHPA, speaking for 26 million health professionals worldwide, urged WHO and Member States not to lose sight of person-centred care and people-centred public health, when considering noncommunicable disease targets, indicators and a global monitoring system.
Read full WHPA intervention on NCDs 
18 January 2012: WHPA calls on WHO to recognise health professionals’ contributions
In an intervention on WHO Reform given during the WHO 130th Executive Board meeting, WHPA strongly recommended that WHO and the Executive Board recognise the importance of NGOs representing current and future healthcare professionals. (see full text of intervention) |